Drugs
Researchers from the Capital Medical University, College of Pharmaceutical Sciences in Beijing, People's Republic of China, have made significant findings in the discovery of anti-tumoral indoles. A series of benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3',4':1,2]pyridin[3,4-b]indole-2-substituted acetates
Drugs
Oncolytics Biotech Inc. has announced the initiation of a US Phase 2 clinical trial utilizing intravenous administration of REOLYSIN in combination with carboplatin and paclitaxel in patients with squamous cell carcinoma of the lungs (SCC lung cancer). This clinical trial aims to assess the antitumor effect of the treatment regimen
Drugs
Recent research from Madrid, Spain, reveals that non-small-cell lung cancer (NSCLC) accounts for approximately 80%-85% of all cases of lung cancer, with stage III disease making up around 40% of all cases. For patients with unresectable stage III NSCLC, the treatment typically involves a combination of platinum-based chemotherapy and
Drugs
Researchers from Nanjing, People's Republic of China, have made a significant discovery in the field of cancer gene therapy. By down-regulating the expression of heat shock protein 27 (HSP27), the team was able to sensitize TRAIL-resistant tumor cells to TRAIL-induced apoptosis. This breakthrough has important implications for the
Drugs
A candid discussion took place at the National Comprehensive Cancer Network's 15th Annual Conference on Clinical Practice Guidelines & Quality Cancer Care on March 11, 2010, between ABC News anchor and cancer survivor Sam Donaldson, a panel of experts, and patients and family members who have faced end
Drugs
Researchers from Hong Kong have made a breakthrough in the treatment of non-small cell lung cancer (NSCLC), a type of cancer that accounts for approximately 85% of all lung cancer cases. According to a report published in Discovery Medicine, the Iressa Pan-Asia Study (IPASS) has shown that patients with a
Drugs
Scientists at Duquesne University's Pharmaceutical Sciences Division have designed, synthesized, and evaluated two novel compounds that have shown promise in cancer treatment. These single agents, which combine antiangiogenic and cytotoxic effects, have been tested in a mouse model and have demonstrated significant tumor growth inhibition, inhibition of metastasis,
Drugs
Researchers at the National Tsing-Hua University in Hsinchu, Taiwan, have made a groundbreaking discovery in the field of cancer treatment. By combining two existing anti-inflammatory drugs, troglitazone and aspirin, the team led by K.H. Yan has found that the resulting synergy can produce a strong anticancer effect, arresting cell
Drugs
Scientists have investigated the mechanism of 10-methoxy-9-nitrocamptothecin (MONCPT)-induced cell cycle arrest in A549 cells, finding that the p53 and p38 MAPK pathways are involved. This research has significant implications for anticancer therapy. By examining the effects of MONCPT on cell cycle distribution, protein expression, and RNA expression, researchers have
Drugs
Researchers have found that antiviral therapy significantly reduces the risk of hepatocellular carcinoma (HCC) in patients with hepatitis C virus (HCV)-related cirrhosis. This conclusion was drawn from a systematic review and meta-analysis of 20 studies, involving 4,700 patients, that compared untreated patients with those given interferon (IFN) alone
Drugs
Researchers from Vanderbilt University have made a groundbreaking discovery in the field of cancer treatment, detailing new data in mass spectrometry that can detect tumor dependence on the epidermal growth factor receptor (EGFR) pathway in cancer patients. The study, published in Cancer Epidemiology, Biomarkers & Prevention, analyzed serum proteomic profiles
Drugs
A new study provides insights into the management of hepatitis B virus (HBV) infection through liver transplantation, highlighting the need for a consensus standard regimen for treatment. The study, conducted by scientists in Hangzhou, People's Republic of China, reveals the limitations of current therapies and the potential benefits
